Skip to main content
Log in

Effect of ponsinomycin on cyclosporin pharmacokinetics

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The influence of treatment with ponsinomycin, a new macrolide antibiotic, on the pharmacokinetics of cyclosporin A has been studied in 10 renal transplant patients. The pharmacokinetics of cyclosporin A was investigated at steady state, before and during treatment with ponsinomycin.

On average, the blood levels of cyclosporin A were doubled by the macrolide, possibly due to a decrease in elimination or/and to an increase in absorption.

Ponsinomycin should be use very carefully in patients treated with cyclosporin A.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Baciewicz AM, Baciewicz FA (1989) Cyclosporine pharmacokinetic drug interactions. Am J Surg 157: 264–271

    Google Scholar 

  • Bowers LD, Canafax DM, Singh J, Seifedlin R, Simmons RL, Najarian JS (1986) Studies of cyclosporine blood level: analysis, clinical, utility, pharmacokinetics, metabolites and chronopharmacology. Transpl Proc 18 (5): 137–143

    Google Scholar 

  • Couet W, Ingrand I, Reigner B, Girault J, Bizouard J, Fourtillan JB (1989) Lack of effect of ponsinomycin on the plasma pharmacokinetics of theophylline. Eur J Clin Pharmacol 37: 101–104

    Google Scholar 

  • Couet W, Istin B, Ingrand I, Girault J, Fourtillan JB (1990) Effect of ponsinomycin on single-dose kinetics and metabolism of carbamazepine. Ther Drug Monit 12: 144–149

    Google Scholar 

  • Cockroft DN, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31–41

    Google Scholar 

  • Freeman DJ, Martell R, Carruthers SG, Heinrichs D, Keown PA, Stiller CR (1987) Cyclosporin-erythromycin interaction in normal subjects. Br J Clin Pharmacol 23: 776–778

    Google Scholar 

  • Gonwa TA, Nghiem DD, Schulak JA, Corry RJ (1986) Erythromycin and cyclosporine. Transplant 41: 797–799

    Google Scholar 

  • Guillemain R, Billaud E, Dreyfus G, Amrein C, Kitzis M, Jebara VA, Kreft-Jais C (1989) The effects of spiramycin on plasma cyclosporin A concentrations in heart transplant patients. Eur J Clin Pharmacol 36: 97–98

    Google Scholar 

  • Gupta SK, Bakran A, Johnson RWG, Rowland M (1989) Cyclosporin-erythromycin interaction in renal transplants patients. Br J Clin Pharmacol 27: 475–481

    Google Scholar 

  • Hourmant M, Le Bigot JF, Vernillet L, Sagniez G, Remi JP, Soulillou JP (1985) Coadministration of erythromycin results in an increase of blood cyclosporine to toxic levels. Transplant Proc 17: 2723–2727

    Google Scholar 

  • Kahan BD (1985) Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplant 40: 457–476

    Google Scholar 

  • Kessler M, Louis J, Renoult E, Vigneron B, Netter P (1986) Interaction between cyclosporin and erythromycin in a kidney transplant patient (letter). Eur J Clin Pharmacol 30: 633–634

    Google Scholar 

  • Kreft-Jais C, Billaud EM, Gaudry C, Bedrossian J (1987) Effect of josamycin on plasma cyclosporine levels (letter). Eur J Clin Pharmacol 32: 327–328

    Google Scholar 

  • Ludden TM (1985) Pharmacokinetic interaction of the macrolide antibiotic. Clin Pharm 10: 63–79

    Google Scholar 

  • Murray BM, Edwards L, Morse GD, Kohli RR, Venuto RC (1987) Clinically important interaction of cyclosporine and erythromycin. Transplant 43: 602–604

    Google Scholar 

  • Penouil F, Morel D, Saux MC, Brachet-Liermain A, Potaux L, Aparicio M (1988) Resorption de la ciclosporine administrée par voie orale à des transplantés rénaux: influence d'un petit déjeuner et d'un médicament anti-acide. Thérapie 43: 15–19

    Google Scholar 

  • Principi N, Onorato J, Giuliani MG, Vigano A (1987) Effect of miocamycin on theophylline kinetics in children. Eur J Clin Pharmacol 31: 701–704

    Google Scholar 

  • Ptachcinski RJ, Carpenter BJ, Burckart GJ, Venkataramanan R, Rosenthal JT (1985) Effect of erythromycin on cyclosporine levels. N Engl J Med 313: 1416–1417

    Google Scholar 

  • Reymond JP, Steimer JL, Niederberger W (1988) On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers. J Pharmacokinet Biopharm 16 (4): 331–353

    Google Scholar 

  • Rodighiero V (1989) Therapeutic drug monitoring of cyclosporin: practical applications and limitations. Clin Pharm 16: 27–37

    Google Scholar 

  • Shawchuck RJ, Cartier LL (1981) Liquid chromatographic determination of cyclosporine A in blood and plasma. Clin Chem 27: 1368–1371

    Google Scholar 

  • Venkataramanan R, Yang S, Burckart GJ, Ptachcinski RJ, Van Thiel DH (1986) Diurnal variation in cyclosporine kinetics. Ther Drug Monit 8: 380–381

    Google Scholar 

  • Vernillet L, Bertault-Peres P, Berland Y, Barradas J, Durand A, Olmer M (1989) Lack of effect of spiramycin on cyclosporin pharmacokinetics. Br J Clin Pharmacol 27: 789–794

    Google Scholar 

  • Wadhwa NK, Schroeder TJ, Pesce AJ, Myre SA, Clardy CW, Roy First (1987) Cyclosporine drug interactions: a review. Ther Drug Monit 9: 399–406

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Couet, W., Istin, B., Seniuta, P. et al. Effect of ponsinomycin on cyclosporin pharmacokinetics. Eur J Clin Pharmacol 39, 165–167 (1990). https://doi.org/10.1007/BF00280052

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00280052

Key words

Navigation